Journal
TRAVEL MEDICINE AND INFECTIOUS DISEASE
Volume 12, Issue 5, Pages 422-428Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.tmaid.2014.06.007
Keywords
MERS-CoV; SARS-CoV; Hajj: zoonosis; Travel
Funding
- KSA Ministry of Health
- National Institute of Health Research Biomedical Research Centre
- University College London Hospitals
- European and Developing Countries Clinical Trials Partnership
- EC-FW7
Ask authors/readers for more resources
The emergence of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and of the Middle East Syndrome Cornavirus (MERS-CoV) caused widespread fear and concern for their potential threat to global health security. There are similarities and differences in the epidemiology and clinical features between these two diseases. The origin of SARS-COV and MERS-CoV is thought to be an animal source with subsequent transmission to humans. The identification of both the intermediate host and the exact route of transmission of MERS-CoV is crucial for the subsequent prevention of the introduction of the virus into the human population. So far MERS-CoV had resulted in a limited travel-associated human cases with no major events related to the Hajj. (C) 2014 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available